XML 46 R35.htm IDEA: XBRL DOCUMENT v3.3.1.900
Related Party Transactions (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Sep. 30, 2013
Sep. 30, 2015
General and administrative expenses $ 3,044,855 $ 16,383    
Second Stock Option [Member]        
Number of vested shares     500,000  
Exercise price     $ 1.60  
Expiry date     Jul. 05, 2023  
Restricted Common Stock [Member]        
Non-cash stock option and stock compensation charges 610,000 0    
Common stock vested awards 250,000 0    
Additional compensation obligations associated with vesting $ 2,290,341 $ 0    
Fair value of non-cash stock compensation charges per share $ 2.44      
Common shares to be issued $ 1,000,000      
Directors and Officers [Member]        
Non-cash stock option and stock compensation charges 746,514      
Recognized stock based compensation expense 2,290,341      
Accounts payable and accrued liabilities $ 47,000     $ 33,000
Directors and Officers [Member] | Restricted Common Stock [Member] | Share-based Compensation Award, Tranche One [Member]        
Stock based compensation award vesting in percentage 25.00%      
Description stock based compensation award vesting

Company starting a Phase Ib/IIb human study.

     
Common shares to be issued $ 610,000      
Directors and Officers [Member] | Restricted Common Stock [Member] | Share-based Compensation Award, Tranche Two [Member]        
Stock based compensation award vesting in percentage 25.00%      
Description stock based compensation award vesting

Company in-licensing additional assets in clinical or pre-clinical stage.

     
Common shares to be issued $ 610,000      
Directors and Officers [Member] | Restricted Common Stock [Member] | Share-based Compensation Award, Tranche Three [Member]        
Stock based compensation award vesting in percentage 25.00%      
Description stock based compensation award vesting

Company securing additional non-dilutive equity funding in 2013 of at least $5,000,000 with a share price higher than the previous funding.

     
Common shares to be issued $ 610,000      
Directors and Officers [Member] | Restricted Common Stock [Member] | Share-based Compensation Award, Tranche Four [Member]        
Stock based compensation award vesting in percentage 25.00%      
Description stock based compensation award vesting

Company obtaining a listing on a major stock exchange.

     
Common shares to be issued $ 610,000